Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...
With automated proof-checkers, a problem can be broken up into small chunks, solved bit-by-bit, then reassembled with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results